Skip to main content

Animations

MJFF Publications

2851 - 2860 of 9036 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2023
  • 2023
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Association of Mitochondrial DNA Genomic Variation With Risk of Pick Disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011649
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000011464
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.626974
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.13168
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Computational medication regimen for Parkinson’s disease using reinforcement learning
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-88619-4
    Citation Count: 28
  • Summary Details
    OPEN
    Title: High-throughput generation of midbrain dopaminergic neuron organoids from reporter human pluripotent stem cells
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xpro.2021.100463
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Development and early qualitative evidence of two novel patient-reported outcome instruments to assess daily functioning in people with early-stage Parkinson’s
    Journal Name: Journal of Patient-Reported Outcomes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s41687-023-00577-9
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-37464-2
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Transcript Variants of Genes Involved in Neurodegeneration Are Differentially Regulated by the APOE and MAPT Haplotypes
    Journal Name: Genes
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/genes12030423
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein
    Journal Name: Journal of Neuroscience Research
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jnr.24782
    Citation Count: 40
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.